Klaria Pharma Holding AB (publ.) (KLAR.ST)

SEK 1.05

(-1.41%)

Gross Profit Summary of Klaria Pharma Holding AB (publ.)

Klaria Pharma Holding AB (publ.)'s latest annual gross profit in 2023 was -9000.00 SEK , down -100.15% from previous year.
Klaria Pharma Holding AB (publ.)'s latest quarterly gross profit in 2024 Q2 was -2000.00 SEK , down -125.0% from previous quarter.
Klaria Pharma Holding AB (publ.) reported a annual gross profit of 5.86 Million SEK in annual gross profit 2022, up 220.91% from previous year.
Klaria Pharma Holding AB (publ.) reported a annual gross profit of -4.85 Million SEK in annual gross profit 2021, up 21.88% from previous year.
Klaria Pharma Holding AB (publ.) reported a quarterly gross profit of 8000.00 SEK for 2024 Q1, up 100.11% from previous quarter.
Klaria Pharma Holding AB (publ.) reported a quarterly gross profit of -2.75 Million SEK for 2023 Q2, down -142.26% from previous quarter.

Annual Gross Profit Chart of Klaria Pharma Holding AB (publ.) (2023 - 2014)

Historical Annual Gross Profit of Klaria Pharma Holding AB (publ.) (2023 - 2014)

Year	Gross Profit	Gross Profit Growth
2023	-9000.00 SEK	-100.15%
2022	5.86 Million SEK	220.91%
2021	-4.85 Million SEK	21.88%
2020	-6.21 Million SEK	-247.1%
2019	4.22 Million SEK	147.29%
2018	-8.93 Million SEK	-492.53%
2017	2.27 Million SEK	25377.78%
2016	-9000.00 SEK	0.0%
2015	- SEK	100.0%
2014	-301.07 Thousand SEK	0.0%

Year	Gross Profit	Gross Profit Growth
2024 Q2	-2000.00 SEK	-125.0%
2024 Q1	8000.00 SEK	100.11%
2023 Q2	-2.75 Million SEK	-142.26%
2023 Q3	619 Thousand SEK	122.44%
2023 FY	-9000.00 SEK	-100.15%
2023 Q4	-7.15 Million SEK	-1255.09%
2023 Q1	6.52 Million SEK	195.52%
2022 Q2	900 Thousand SEK	132.64%
2022 Q1	-2.75 Million SEK	-183.29%
2022 Q4	2.2 Million SEK	227.91%
2022 FY	5.86 Million SEK	220.91%
2022 Q3	-1.72 Million SEK	-291.89%
2021 Q3	-2.71 Million SEK	0.33%
2021 Q2	-2.72 Million SEK	0.0%
2021 Q4	3.31 Million SEK	221.92%
2021 FY	-4.85 Million SEK	21.88%
2021 Q1	-2.72 Million SEK	-319.85%
2020 Q3	3.4 Million SEK	207.32%
2020 FY	-6.21 Million SEK	-247.1%
2020 Q4	1.23 Million SEK	-63.58%
2020 Q2	1.1 Million SEK	-24.8%
2020 Q1	1.47 Million SEK	700.0%
2019 Q3	91 Thousand SEK	-26.61%
2019 Q2	124 Thousand SEK	-96.76%
2019 Q1	3.82 Million SEK	1670.37%
2019 FY	4.22 Million SEK	147.29%
2019 Q4	184 Thousand SEK	102.2%
2018 Q1	83 Thousand SEK	5.06%
2018 FY	-8.93 Million SEK	-492.53%
2018 Q3	92 Thousand SEK	-64.34%
2018 Q2	258 Thousand SEK	210.84%
2018 Q4	216 Thousand SEK	134.78%
2017 Q2	- SEK	0.0%
2017 Q4	79 Thousand SEK	-96.53%
2017 Q3	2.27 Million SEK	0.0%
2017 FY	2.27 Million SEK	25377.78%
2017 Q1	- SEK	0.0%
2016 Q3	- SEK	0.0%
2016 FY	-9000.00 SEK	0.0%
2016 Q4	- SEK	0.0%
2016 Q1	- SEK	0.0%
2016 Q2	- SEK	0.0%
2015 Q1	- SEK	0.0%
2015 Q2	- SEK	0.0%
2015 Q3	- SEK	0.0%
2015 Q4	- SEK	0.0%
2015 FY	- SEK	100.0%
2014 FY	-301.07 Thousand SEK	0.0%

Peer Gross Profit Comparison of Klaria Pharma Holding AB (publ.)

Name	Gross Profit	Gross Profit Difference
AcuCort AB	6.59 Million SEK	100.137%
AlzeCure Pharma AB (publ)	-476 Thousand SEK	98.109%
BioGaia AB (publ)	950.19 Million SEK	100.001%
Enzymatica AB (publ)	31.86 Million SEK	100.028%
Enorama Pharma AB (publ)	-3.9 Million SEK	99.769%
Gabather AB (publ)	- SEK	Infinity%
Moberg Pharma AB (publ)	-2.09 Million SEK	99.571%
Nanexa AB (publ)	59.15 Million SEK	100.015%
Newbury Pharmaceuticals AB (publ)	16.03 Million SEK	100.056%
ODI Pharma AB	-1.34 Million SEK	99.329%
Orexo AB (publ)	549.9 Million SEK	100.002%
Probi AB (publ)	220.21 Million SEK	100.004%
Swedencare AB (publ)	164.8 Million SEK	100.005%
Swedish Orphan Biovitrum AB (publ)	14.05 Billion SEK	100.0%
Toleranzia AB	-919 Thousand SEK	99.021%
Vivesto AB	-10.65 Million SEK	99.916%